Granted Patent
B2
US 9,518,083 · App. 14/618,613 · Granted Dec 13, 2016
Gadd45beta targeting agents
Inventors:
Guido Franzoso (London, GB); Albert Andrzej Jaxa-Chamiec (London, GB); Caroline Minli Rachel Low (London, GB); Simona Maria Monti (Naples, IT); Menotti Ruvo (Naples, IT); Laura Tornatore (London, GB); Catherine Jane Tralau-Stewart (London, GB)
Assignee:
Imperial Innovations Limited
View Patent ↗
Loading inventors, assignments & file history…
Abstract
Compounds based around tetrapeptide, tripeptide and dipeptide moeties and corresponding peptiod moeties. Related methods and pharmaceutical compositions for use in treatment of cancer, inflammatory diseases, and other disorders.
Claims (3)
1. A compound according to Formula I
or a pharmaceutically acceptable salt thereof.
2. A pharmaceutical composition comprising the compound of claim 1 and a pharmaceutically acceptable excipient.
Assignments (3)
CHANGE OF NAME
Recorded Dec 8, 2020
From: IMPERIAL INNOVATIONS LIMITED
To: IP2IPO INNOVATIONS LIMITED
Reel/Frame 054577/0166 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 8, 2020
From: IP2IPO INNOVATIONS LIMITED
To: IMPERIAL COLLEGE INNOVATIONS LIMITED
Reel/Frame 054577/0449 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 19, 2015
From: FRANZOSO, GUIDO; JAXA-CHAMIEC, ALBERT ANDRZEJ; LOW, CAROLINE MINLI RACHEL; MONTI, SIMONA MARIA; RUVO, MENOTTI; TORNATORE, LAURA; TRALAU-STEWART, CATHERINE JANE
To: IMPERIAL INNOVATIONS LIMITED
Reel/Frame 034981/0982 →
Priority Claims (1)
GB 09185794
· Oct 22, 2009
· national
Continuity (2)
Continuation
13502781